Thomas P Moyer

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles
    Thomas P Moyer
    Drug Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
    Clin Chem 48:1460-71. 2002
  2. ncbi Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users
    Jon O Ebbert
    Department of Internal Medicine, Division of Community Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Addict Behav 29:349-55. 2004
  3. ncbi Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    J Matern Fetal Neonatal Med 17:281-9. 2005
  4. ncbi Hereditary hemochromatosis: laboratory evaluation
    Thomas P Moyer
    Department of Laboratory Medicine and Pathology, Division of Clinical Biochemistry and Immunology, Mayo Clinic, Rochester, MN 55905, United States
    Clin Chim Acta 412:1485-92. 2011
  5. ncbi Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users
    Jon O Ebbert
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Nicotine Tob Res 9:43-52. 2007
  6. ncbi Nicotine percentage replacement among smokeless tobacco users with nicotine patch
    Jon O Ebbert
    Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
    Drug Alcohol Depend 89:223-6. 2007
  7. ncbi Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine
    Donald E McAlpine
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Ther Drug Monit 33:14-20. 2011
  8. ncbi Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy
    Robert A Wermers
    Department of Internal Medicine, Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 First Street S W, Rochester, MN 55905, USA
    Clin Infect Dis 52:604-11. 2011
  9. ncbi Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis
    Kevin N Christensen
    Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA
    J Am Acad Dermatol 64:91-6. 2011
  10. ncbi Iqmik: a form of smokeless tobacco used among Alaska natives
    Caroline C Renner
    Office of Alaska Native Health Research, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Am J Health Behav 29:588-94. 2005

Collaborators

Detail Information

Publications12

  1. ncbi Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profiles
    Thomas P Moyer
    Drug Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
    Clin Chem 48:1460-71. 2002
    ..Absence of nicotine metabolites and anabasine can be used to document abstinence from tobacco products, an indicator of treatment success...
  2. ncbi Cotinine as a biomarker of systemic nicotine exposure in spit tobacco users
    Jon O Ebbert
    Department of Internal Medicine, Division of Community Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Addict Behav 29:349-55. 2004
    ....
  3. ncbi Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonates
    Richard D Hurt
    Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
    J Matern Fetal Neonatal Med 17:281-9. 2005
    ..To determine the concentration of nicotine and cotinine in maternal blood and neonatal cord blood among pregnant Alaska Native women and to assess the neonates for neurobehavioral effects...
  4. ncbi Hereditary hemochromatosis: laboratory evaluation
    Thomas P Moyer
    Department of Laboratory Medicine and Pathology, Division of Clinical Biochemistry and Immunology, Mayo Clinic, Rochester, MN 55905, United States
    Clin Chim Acta 412:1485-92. 2011
    ..Because hepcidin also plays a key role in antimicrobial and inflammatory activities, interpretation of hepcidin serum or urine concentration will require thorough understanding of its complex role in iron regulation...
  5. ncbi Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users
    Jon O Ebbert
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Nicotine Tob Res 9:43-52. 2007
    ..High-dose nicotine patch therapy is safe and well tolerated in this population of tobacco users...
  6. ncbi Nicotine percentage replacement among smokeless tobacco users with nicotine patch
    Jon O Ebbert
    Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
    Drug Alcohol Depend 89:223-6. 2007
    ..We conclude that the use of 42 mg/day nicotine patch therapy is safe and should be considered as initial therapy in the clinical setting among ST users who use > or =3 cans/week...
  7. ncbi Effect of cytochrome P450 enzyme polymorphisms on pharmacokinetics of venlafaxine
    Donald E McAlpine
    Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Ther Drug Monit 33:14-20. 2011
    ....
  8. ncbi Fluoride excess and periostitis in transplant patients receiving long-term voriconazole therapy
    Robert A Wermers
    Department of Internal Medicine, Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, 200 First Street S W, Rochester, MN 55905, USA
    Clin Infect Dis 52:604-11. 2011
    ..Elevated plasma and bone fluoride levels were identified. Discontinuation of voriconazole therapy led to improvement in pain and reduced fluoride and alkaline phosphatase levels...
  9. ncbi Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis
    Kevin N Christensen
    Mayo Medical School, Mayo Clinic, Rochester, Minnesota, USA
    J Am Acad Dermatol 64:91-6. 2011
    ..To date, all efforts to investigate skin Gd concentrations in patients with NSF have been performed on paraffin-embedded samples, and Gd deposition has not been correlated with disease activity by a statistically significant analysis...
  10. ncbi Iqmik: a form of smokeless tobacco used among Alaska natives
    Caroline C Renner
    Office of Alaska Native Health Research, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
    Am J Health Behav 29:588-94. 2005
    ..To describe a homemade form of smokeless tobacco known as Iqmik used among Alaska Natives residing in western Alaska...
  11. ncbi Differentiation of amphetamine/methamphetamine and other cross-immunoreactive sympathomimetic amines in urine samples by serial dilution testing
    Alison Woodworth
    Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA
    Clin Chem 52:743-6. 2006
    ....
  12. ncbi National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department
    Alan H B Wu
    Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT 06102, USA
    Clin Chem 49:357-79. 2003
    ..As no clinical laboratory can provide services to meet all needs, the National Academy of Clinical Biochemistry Committee recommends establishment of regional centers for specialized toxicology testing...